Kathleen M. Coerdt
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kathleen M. Coerdt has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Amor Khachemoune
Department of Dermatology, State University of New York Downstate and Veterans Affairs Medical Center, Brooklyn, New York
1 shared publication - Amy G. Starr
Department of Pathology, MedStar Georgetown University Hospital, Washington, D.C., USA
1 shared publication - Christopher E. Attinger
Department of Plastic and Reconstructive Surgery, Medstar Georgetown University Hospital, Washington, DC 20007, USA
1 shared publication Cynthia M. C. DeKlotz
Georgetown University School of Medicine Washington DC USA
1 shared publication- Elizabeth G. Zolper
Georgetown University School of Medicine, Washington, DC, USA
1 shared publication - Emily L. Guo
Dermatology & Laser Surgery Center Houston Texas USA
1 shared publication
Latest Publications
- Open Access
- 16 April 2021
- Published by African Journals Online (AJOL) in African Health Sciences
- Vol. 21 (1) , 207-13
Corona viruses: reaching far beyond the common cold
Background: Human coronaviruses (HCoVs) are one of the most common causes of the “common cold”. Some HCoV strains, however, can cause fatal respiratory disease. Some examples of these diseases are severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and Coronavirus Disease 19 (COVID-19). This article will review the etiology, clinical features, diagnosis, and management of HCoVs. Methods: A systematic literature review was performed using the terms “human coronaviruses”, “MERS-CoV”, “SARS- CoV”, “SARS-CoV2”, “COVID-19”, and “common cold” in OVID MEDLINE, PubMed, and Cochrane Library. Findings: Most HCoVs cause mild upper respiratory infections which resolve with supportive care and no sequelae. In recent decades, however, there have been outbreaks of novel HCoVs that cause more severe disease. This is largely due to HCoVs having large genomes which undergo frequent recombination events, leading to the emergence of novel and more virulent strains of the virus. These severe respiratory illnesses can lead to acute respiratory distress requiring invasive intervention, such as mechanical ventilation. These severe infections can lead to long-lasting sequelae in patients. Scientists continue to investigate potential treatments for these viruses, though supportive care remains the gold standard. Scientists have succeeded in devel- oping numerous vaccines for the SARS-CoV-2 virus, and ongoing data collection and analysis will shed even more light on the next steps in fighting the COVID-19 pandemic. Conclusion: Due to the frequency of recombination events and the subsequent emergence of novel strains, HCoVs are be- coming more prevalent, making them a global health concern as they can lead to epidemics and pandemics. Understanding the epidemiology, etiology, clinical features, diagnosis, and management of HCoVs is important, especially during this worldwide pandemic. Keywords: Coronavirus; common cold; severe respiratory disease; COVID-19.
- 16 April 2021
- Published by African Journals Online (AJOL) in African Health Sciences
- Vol. 21 (1) , 207-13
Open AccessCorona viruses: reaching far beyond the common cold
Background: Human coronaviruses (HCoVs) are one of the most common causes of the “common cold”. Some HCoV strains, however, can cause fatal respiratory disease. Some examples of these diseases are severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and Coronavirus Disease 19 (COVID-19). This article will review the etiology, clinical features, diagnosis, and management of HCoVs. Methods: A systematic literature review was performed using the terms “human coronaviruses”, “MERS-CoV”, “SARS- CoV”, “SARS-CoV2”, “COVID-19”, and “common cold” in OVID MEDLINE, PubMed, and Cochrane Library. Findings: Most HCoVs cause mild upper respiratory infections which resolve with supportive care and no sequelae. In recent decades, however, there have been outbreaks of novel HCoVs that cause more severe disease. This is largely due to HCoVs having large genomes which undergo frequent recombination events, leading to the emergence of novel and more virulent strains of the virus. These severe respiratory illnesses can lead to acute respiratory distress requiring invasive intervention, such as mechanical ventilation. These severe infections can lead to long-lasting sequelae in patients. Scientists continue to investigate potential treatments for these viruses, though supportive care remains the gold standard. Scientists have succeeded in devel- oping numerous vaccines for the SARS-CoV-2 virus, and ongoing data collection and analysis will shed even more light on the next steps in fighting the COVID-19 pandemic. Conclusion: Due to the frequency of recombination events and the subsequent emergence of novel strains, HCoVs are be- coming more prevalent, making them a global health concern as they can lead to epidemics and pandemics. Understanding the epidemiology, etiology, clinical features, diagnosis, and management of HCoVs is important, especially during this worldwide pandemic. Keywords: Coronavirus; common cold; severe respiratory disease; COVID-19.
- Open Access
- 7 March 2021
- Published by Georg Thieme Verlag KG in Archives of Plastic Surgery
- Vol. 48 (02) , 231-236
Cutaneous mucormycosis of the lower extremity leading amputation in two diabetic patients
Mucormycosis is an invasive, rapidly progressive, life-threatening fungal infection, with a propensity for diabetic, immunosuppressed, and trauma patients. The classic rhinocerebral variation is most common in diabetic patients. While the cutaneous form is usually caused by direct inoculation in immunocompetent patients. Cutaneous mucormycosis manifests in soft tissue and risks involvement of underlying structures. Tibial osteomyelitis can also occur secondary to cutaneous mucormycosis but is rare. Limb salvage is typically successful after lower extremity cutaneous mucormycosis even when the bone is involved. Herein, we report two cases of lower extremity cutaneous mucormycosis in diabetic patients that presented as acute worsening of chronic pretibial ulcers. Despite aggressive antifungal therapy and surgical debridement, both ultimately required amputation. Such aggressive presentation has not been reported in the absence of major penetrating trauma, recent surgery, or burns.
- 7 March 2021
- Published by Georg Thieme Verlag KG in Archives of Plastic Surgery
- Vol. 48 (02) , 231-236
Open AccessCutaneous mucormycosis of the lower extremity leading amputation in two diabetic patients
Mucormycosis is an invasive, rapidly progressive, life-threatening fungal infection, with a propensity for diabetic, immunosuppressed, and trauma patients. The classic rhinocerebral variation is most common in diabetic patients. While the cutaneous form is usually caused by direct inoculation in immunocompetent patients. Cutaneous mucormycosis manifests in soft tissue and risks involvement of underlying structures. Tibial osteomyelitis can also occur secondary to cutaneous mucormycosis but is rare. Limb salvage is typically successful after lower extremity cutaneous mucormycosis even when the bone is involved. Herein, we report two cases of lower extremity cutaneous mucormycosis in diabetic patients that presented as acute worsening of chronic pretibial ulcers. Despite aggressive antifungal therapy and surgical debridement, both ultimately required amputation. Such aggressive presentation has not been reported in the absence of major penetrating trauma, recent surgery, or burns.
- 1 January 2021
- Published by Wiley in Pediatric Dermatology
- Vol. 38 (1) , 296-298
Topical rapamycin for acanthosis nigricans in the Fitzpatrick IV/V adolescent population
Dermatologically, FGFR3 mutations can lead to acanthosis nigricans (AN), epidermal nevi, and seborrheic keratosis. A recent case report found that topical rapamycin (sirolimus) can improve FGFR3-induced epidermal nevi with AN features in children, specifically with Fitzpatrick skin type (FST) I/II, and we would like to expand these findings to skin plaques with extensive AN-like features in the FST IV/V adolescent population. An 18-year-old female with FST IV/V and FGFR3-induced hypochondroplasia presented to our clinic with extensive AN-like plaques. Significant improvement with lightening and thinning of the plaques was observed after applying 1% topical rapamycin cream twice daily. Topical rapamycin should be considered as a treatment option for AN, particularly in FST IV/V adolescents with FGFR3-induced AN.
- 1 January 2021
- Published by Wiley in Pediatric Dermatology
- Vol. 38 (1) , 296-298
Topical rapamycin for acanthosis nigricans in the Fitzpatrick IV/V adolescent population
Dermatologically, FGFR3 mutations can lead to acanthosis nigricans (AN), epidermal nevi, and seborrheic keratosis. A recent case report found that topical rapamycin (sirolimus) can improve FGFR3-induced epidermal nevi with AN features in children, specifically with Fitzpatrick skin type (FST) I/II, and we would like to expand these findings to skin plaques with extensive AN-like features in the FST IV/V adolescent population. An 18-year-old female with FST IV/V and FGFR3-induced hypochondroplasia presented to our clinic with extensive AN-like plaques. Significant improvement with lightening and thinning of the plaques was observed after applying 1% topical rapamycin cream twice daily. Topical rapamycin should be considered as a treatment option for AN, particularly in FST IV/V adolescents with FGFR3-induced AN.
- 17 April 2020
- Published by Wiley in Pediatric Dermatology
- Vol. 37 (4) , 762-763
The case of missing skin: Congenital Volkmann ischemic contracture
Congenital Volkmann ischemic contracture (CVIC) is an exceedingly rare neonatal compartment syndrome caused by intrauterine ischemia and external compression. It presents at birth with necrotic cutaneous lesions and neurologic impairment, typically in a distal upper extremity. Diagnosis and treatment are often delayed in neonates, leading to long‐term neurologic sequelae. We present a rare case of CVIC in order to raise awareness of its presentation and management in hopes of improving outcomes.
- 17 April 2020
- Published by Wiley in Pediatric Dermatology
- Vol. 37 (4) , 762-763
The case of missing skin: Congenital Volkmann ischemic contracture
Congenital Volkmann ischemic contracture (CVIC) is an exceedingly rare neonatal compartment syndrome caused by intrauterine ischemia and external compression. It presents at birth with necrotic cutaneous lesions and neurologic impairment, typically in a distal upper extremity. Diagnosis and treatment are often delayed in neonates, leading to long‐term neurologic sequelae. We present a rare case of CVIC in order to raise awareness of its presentation and management in hopes of improving outcomes.
- 6 January 2020
- Published by Taylor & Francis in Journal of Dermatological Treatment
- Vol. 32 (7) , 860-861
Clinical recommendations made in dermatology publications are frequently not supported by adequate evidence
Objectives: Absolute risk and cost-benefit analyses are necessary to guide clinical decision making. The purpose of this study was to evaluate whether clinical recommendations in dermatology publications were supported by adequate evidence. We also assessed whether dermatology residents report sufficient evidence when they author publications. Methods: We analyzed the clinical cohort, case-control, and case series studies published in JAMA Dermatology and the Journal of American Academy of Dermatology from January 2018 to December 2018 for statistical significance, absolute associations, diagnostic and therapeutic clinical recommendations, and risk-benefit analysis. We also identified articles with a U.S. dermatology resident as first or second author. Results: We found that the majority of articles reported statistical significance, but only 3% included absolute risk analyses and none had risk-benefit analysis. Furthermore, the subset of studies with a dermatology resident as a primary author reported statistical significance in 42%, but none provided absolute risk or risk-benefit analyses. Conclusions: Reviewers need to be more aware of the evidentiary needs required for clinical recommendations, and dermatology residents may benefit from additional statistics training.
- 6 January 2020
- Published by Taylor & Francis in Journal of Dermatological Treatment
- Vol. 32 (7) , 860-861
Clinical recommendations made in dermatology publications are frequently not supported by adequate evidence
Objectives: Absolute risk and cost-benefit analyses are necessary to guide clinical decision making. The purpose of this study was to evaluate whether clinical recommendations in dermatology publications were supported by adequate evidence. We also assessed whether dermatology residents report sufficient evidence when they author publications. Methods: We analyzed the clinical cohort, case-control, and case series studies published in JAMA Dermatology and the Journal of American Academy of Dermatology from January 2018 to December 2018 for statistical significance, absolute associations, diagnostic and therapeutic clinical recommendations, and risk-benefit analysis. We also identified articles with a U.S. dermatology resident as first or second author. Results: We found that the majority of articles reported statistical significance, but only 3% included absolute risk analyses and none had risk-benefit analysis. Furthermore, the subset of studies with a dermatology resident as a primary author reported statistical significance in 42%, but none provided absolute risk or risk-benefit analyses. Conclusions: Reviewers need to be more aware of the evidentiary needs required for clinical recommendations, and dermatology residents may benefit from additional statistics training.